Dr. Rolf F. Poser, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 635 Park Ave, Columbus, WI 53925 Phone: 920-623-5000 Fax: 920-623-0519 |
Nazi S Khan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1511 Park Ave, Columbus, WI 53925 Phone: 920-623-5226 Fax: 920-623-5252 |
Dr. Samuel G. Poser, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 635 Park Ave, Columbus, WI 53925 Phone: 920-623-5000 Fax: 920-623-0519 |
Dr. Jean Christina Carstensen, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1513 Park Ave Fl 1, Columbus, WI 53925 Phone: 920-623-9611 Fax: 920-623-1787 |
Michael Poser, Internal Medicine Medicare: Medicare Enrolled Practice Location: 635 Park Ave Ste 1, Columbus, WI 53925 Phone: 920-623-5000 |
Bruce A. Kraus, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1515 Park Ave, Columbus, WI 53925 Phone: 920-623-2200 |
Asghar Marwat, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1515 Park Ave, Columbus, WI 53925 Phone: 920-623-1200 |
News Archive
The Editors of Women's Health Issues, the peer-reviewed journal of the Jacobs Institute of Women's Health at The George Washington University School of Public Health and Health Services, are pleased to announce the publication of a new Supplement entitled, Abortion, Reproductive Rights and Health: Highlights from the Charlotte Ellertson Social Science Postdoctoral Fellowship 2003-2010.
Almost one third of students at a university in Uganda say that they have been subject to sexual coercion, an experience which was often linked to risky sexual behaviour. This is shown in a study from Lund University in Sweden.
Governments should consider stockpiling zanamivir as an anti-influenza agent in their pandemic plans, states a Comment in this week's issue of The Lancet.
Organic tomato juice contains more phenolic components than juice from conventionally grown crops, according to a new study published in the journal Food Chemistry directed by Rosa M. Lamuela, a lecturer from the Department of Nutrition and Bromatology of the University of Barcelona (UB) and researcher for the Nutrition and Food Safety Research Institute (INSA) and the Spanish Biomedical Research Centre-Physiopathology of Obesity and Nutrition.
Oncothyreon Inc. today announced enrollment of the first patient in a Phase 1/2 trial of PX-866 in combination with the chimeric monoclonal antibody cetuximab (Erbitux®). PX-866 is a small molecule compound designed to inhibit the activity of phosphatidylinositol-3-kinase (PI-3K), a component of an important cell survival signaling pathway.
› Verified 7 days ago